W.L. Gore & Associates today released data from a long-term study of its Gore Bio-A tissue reinforcement bioabsorbable mesh designed to treat complex ventral hernias in patients with contaminated fields. The study was published in the Annals of Surgery.
Gore’s Bio-A is designed as a web of biocompatible synthetic polymers that are gradually reabsorbed into the body while facilitating tissue generation and healing, according to the company.
The study, which enrolled over 100 subjects, reported a lowered recurrence rate at 17% after 24 months in patients treated with the Gore Bio-A, versus a 39% recurrence rate in patients treated with a biologic mesh.
“I think this study represents an important step forward in defining the most appropriate way to reconstruct complex abdominal wall defects. Bio A performed very well in this challenging group of patients and will provide a cost-effective alternative for reconstructive surgeons,” lead investigator Dr. Michael Rosen of the Cleveland Clinic said in a press release.
Patients treated with Gore’s mesh also reported higher quality of life scores, and faced lessened long-term complications as the mesh did not have to be removed at a later date, Gore said.
“This study proves for the first time something we have believed all along: a biosynthetic mesh can be equivalent or better than a biologic. By being both more cost effective for hospitals and payors while also improving quality of life for patients, GORE BIO-A Tissue Reinforcement is truly advancing healthcare and the way we treat CVH,” general surgical products biz unit leader Ron Anderson said in prepared remarks.
The post Gore touts bioabsorbable hernia mesh study data appeared first on MassDevice.
from MassDevice http://ift.tt/1mATPSc
Cap comentari:
Publica un comentari a l'entrada